ALLR Allarity Therapeutics
- 1.7700
- -0.3400-16.11%
Allarity Therapeutics News
Allarity Therapeutics | 8-K: Current report
Allarity Therapeutics | 8-K: Current report
Allarity Therapeutics | 8-K/A: Current report (Amendment)
Allarity Therapeutics | 8-K: Current report
Allarity Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Allarity Therapeutics | 8-K: Current report
Allarity Therapeutics | DEFR14A: Definitive proxy statement in connection with contested solicitations
Allarity Therapeutics | DEFA14A: Others
Allarity Therapeutics | 8-K: Current report
Allarity Therapeutics | 8-K: Current report
Allarity Therapeutics | DEF 14A: Definitive information statements
Allarity Therapeutics | 8-K: Current report
Allarity Therapeutics | 8-K: Current report
Allarity Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Allarity Therapeutics | 8-K: Current report
Allarity Therapeutics | 8-K: Current report
Allarity Therapeutics | 8-K/A: Current report (Amendment)
Allarity Therapeutics | 8-K: Current report
Allarity Therapeutics | 8-K: Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances
Allarity Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
No Data